DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of DX-8951f in treating children who have
advanced solid tumors or lymphomas that have not responded to previous therapy.